Answers are grounded in this paper and cite their sources.
Monthly malaria forecasts can support diagnostic and treatment planning when the surveillance outcome and evaluation protocol are clearly defined. We analysed 4,128 council-month records from 43 councils in six Lake Zone regions during January 2018–December 2025. Complete mRDT-positive counts were aggregated to 576 region-month observations and one 96-month Lake Zone series. Six fitted models, an equal-weight ensemble and a seasonal-naive benchmark were evaluated on a fixed-origin 2025 holdout and 37 expanding-window origins with 1–12-month horizons. The dataset contained 11,874,519 mRDT-positive counts. Annual counts declined from 1.63 million in 2018 to 1.06 million in 2025, with the highest calendar-month averages in June–July. ARIMA (2, 1, 2) had the lowest 2025 holdout error (MAPE 12.1%; RMSE 11,709), reducing RMSE by 69.2% relative to seasonal naive. Across all rolling origin–horizon pairs, Gradient Boosting had the lowest RMSE (22,007), while the ensemble had the lowest MAE (16,687) and MAPE (16.1%). Model rankings varied with forecast origin, horizon and metric. The findings favour routinely updated, benchmarked forecasts over reliance on a single terminal-year ranking. The outcome represents positive diagnostic counts rather than population-standardized incidence or confirmed unique outpatient episodes.
No takes yet. Share an insight, caveat, or question.
Lugoye et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: